527.20
-5.83%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Astec Lifesciences
Its shares trade on NSE under the ticker ASTEC.NS. It has been listed since 25 November 2009. In the fiscal year to 31 March 2026, it reported revenue of ₹4.48bn and a net loss of ₹809.2m. At that date it held total assets of ₹9.42bn and shareholders' equity of ₹3.91bn.
Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2009-11-25. The firm operates through the Agrochemicals segment. The company manufactures a range of fungicides, insecticides, herbicides, and intermediates for its global customers. The Company’s products and intermediates includes triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, thorium salts, pyrazalone’s and heterocyclic sulfonyl chlorides.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 25 Nov 2009
- Employees
- 551
- Website
- astecls.com ↗
Leadership
Pay as last reported
- Mr. Nadir GodrejNon-Executive Chairman of the Board
- Ms. Mugdha KhareChief Financial Officer
- Ms. Tejashree PradhanCompliance Officer, Company Secretary
- Mr. Burjis GodrejNon-Executive Non-Independent Director
- Mr. Ashok HiremathNon-Executive Non-Independent Director, since 1994₹25.4m
- Mr. Balram YadavNon-Executive Non-Independent Director
- Mr. Nandkumar DhekneNon-Executive Independent Director₹400,000
- Mr. Rishinaradamangalam GovindanNon-Executive Independent Director₹950,000
- Ms. Anjali GupteNon-Executive Independent Director₹400,000
- Mr. Vijay KhotNon-Executive Independent Director₹750,000
- Prof. Dr. Ganapati YadavNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 52
- Environment
- 36
- Social
- 49
- Governance
- 70
- Direct emissions (scope 1)
- 19,072 t
- Energy emissions (scope 2)
- 16,935 t
- Value chain emissions (scope 3)
- 45,092 t
- Women in the workforce
- 5.46%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Astec Lifesciences manufactures a wide range of agrochemicals for global customers.
- The company produces specialized fungicides and insecticides for agricultural use.
- Operations include the production of fluorinated aromatic intermediates for clients.
Weaknesses
- The firm employs only 551 full-time staff members currently.
- Business operations are concentrated solely within the Agrochemicals segment.
- The company relies on manufacturing intermediates rather than finished goods.
Opportunities
- Global demand for triazole fungicides presents growth potential for sales.
- Expansion into heterocyclic herbicides could diversify the current product portfolio.
- Increasing need for synthetic pyrethroids offers new market opportunities.
Threats
- Reliance on a single business segment limits operational diversification.
- Fluctuating raw material costs may impact manufacturing profitability significantly.
- Competition in the chemical sector could reduce market share quickly.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.